The North American Center for Continuing Medical Education, LLC (NACCME), in partnership with HMP Communications, LLC, publisher of EP Lab Digest, today announced several key sessions on the treatment of atrial fibrillation at the upcoming Electrophysiology Innovations Congress--EP Innovations 2010, the world's premier annual electrophysiology meeting, to be held December 9-11, 2010, at the Washington Hilton in Washington, DC.
“Electrophysiology Innovations Congress--EP Innovations 2010 is committed to providing an educational experience unlike any other for practicing electrophysiologists, electrophysiology fellows, electrophysiology allied professionals, and implanting cardiologists”
The comprehensive CME agenda at Electrophysiology Innovations Congress--EP Innovations 2010 will include sessions on risk assessment and prevention of stroke in atrial fibrillation, advanced imaging of atrial fibrillation ablation, epicardial treatment of atrial fibrillation, new antiarrhythmic medications for atrial fibrillation, and current techniques and guidelines for catheter ablation of atrial fibrillation. Electrophysiology Innovations Congress--EP Innovations 2010 will also include moderated panel discussions, noted debates, and several industry-supported symposia.
"Electrophysiology Innovations Congress--EP Innovations 2010 is committed to providing an educational experience unlike any other for practicing electrophysiologists, electrophysiology fellows, electrophysiology allied professionals, and implanting cardiologists," said course co-director Seth Worley, MD, President and Director of Electrophysiology Research, Lancaster Heart and Stroke Foundation in Lancaster, PA. Co-director Kenneth Ellenbogen, MD, Kontos Professor of Medicine and Chairman, Division of Cardiology, Virginia Commonwealth University School of Medicine, Richmond, VA, added, "The format is intended to provide cutting-edge education on innovative technologies and treatments about critical processes and procedures in the treatment of patients commonly seen in the clinic and lab, and attendees are encouraged to present difficult cases to generate discussion."
Liraglutide activates key brain circuits to trigger weight loss in obesity